| Jeremy James Benoit, DO | |
|
2500 N State St, Jackson, MS 39216 | |
| (601) 984-5582 | |
| Not Available |
| Full Name | Jeremy James Benoit |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033572458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | T-3083 (Mississippi) | Secondary |
| 207P00000X | Emergency Medicine | 25635 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thibodaux Regional Medical Center | Thibodaux, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thibodaux Emergency Physicians Group Llc | 2769760537 | 7 |
News Archive
Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
A new investigation published in JAMA Psychiatry finds that while insurance coverage for depression has increased, treatment rates are lower than expected, indicating that non-financial barriers to patient care still remain.
Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.
› Verified 5 days ago
| Entity Name | Thibodaux Emergency Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568910503 PECOS PAC ID: 2769760537 Enrollment ID: O20161028001769 |
News Archive
Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
A new investigation published in JAMA Psychiatry finds that while insurance coverage for depression has increased, treatment rates are lower than expected, indicating that non-financial barriers to patient care still remain.
Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy James Benoit, DO 2500 N State St, Jackson, MS 39216-4500 Ph: () - | Jeremy James Benoit, DO 2500 N State St, Jackson, MS 39216 Ph: (601) 984-5582 |
News Archive
Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
A new investigation published in JAMA Psychiatry finds that while insurance coverage for depression has increased, treatment rates are lower than expected, indicating that non-financial barriers to patient care still remain.
Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.
› Verified 5 days ago
Laura Elizabeth Vearrier, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-2005 | |
Dr. Melanie Fox, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Mohsin Saber, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 N State St, Department Of Emergency Medicine, Jackson, MS 39201 Phone: 601-984-5582 Fax: 601-984-5583 | |
Dr. Gabriel William Tonkin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N. State St., Dept. Of Emergency Medicine, Jackson, MS 39216 Phone: 601-984-5582 | |
John C Brooks, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 N State St, Jackson, MS 39202 Phone: 601-982-6001 Fax: 601-982-8616 | |
Bob Hutchins, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3502 W Northside Dr, Jackson, MS 39213 Phone: 601-362-5321 Fax: 601-364-2600 | |
Lana Ngoc Phan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1850 Chadwick Dr, Jackson, MS 39204 Phone: 601-376-1000 |